Search Results 1-10 of 12501 for %EC%B2%9C%EC%95%88%EC%BD%9C%EA%B1%B8%E3%80%90%EC%B9%B4%ED%86%A1%EC%83%81%EB%8B%B4:vB20%E3%80%91

  2. Macitentan in Pulmonary.

  3. A Study to Evaluate MEDI2228 in Subjects with Relapsed/ Refractory Multiple Myeloma - Mayo Clinic

    About this study. The purpose of this study is to assess the safety, pharmacokinetics and tolerability, describe the dose-limiting toxicities (DLTs), ...

  4. Center for Computational Biotechnology and Genomic Medicine CCBGM.

  5. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

    The purpose of this study is to compare the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper ...

  7. ... EA ADD HR,177,187.00, 260000007,HC IV INF THER INIT 1ST HR,454,482.00, 260000008,HC IV PUSH EA ADD SEQ DRUG,180,185.00, 260000009,HC IV PUSH EA ADD SEQ NEW ...

  8. ... EA ADD HR,125,150, 260000007,HC IV INF THER INIT 1ST HR,400,460, 260000008,HC IV PUSH EA ADD SEQ DRUG,108,143, 260000009,HC IV PUSH EA ADD SEQ NEW DRUG ...

  9. Congress of Neurological Surgeons CNS - Education.

  10. Laboratories - Mayo Clinic Research

    V. Vaccine Research Group: Gregory A. Poland, Richard B. Kennedy, Inna G. Ovsyannikova · Vascular and Interventional Radiology Translational Research: ...